| 61/297 | US=1-A / Farmacologia Krensky AM, Vicenti F, Bennett WM. Imunossupressores, tolerógenos e imunoestimulantes. In: Brunton LL, Lazo JS, Parker KL. Goodman & Gilman: as bases farmacológicas da terapêutica. 11ª ed. Porto Alegre: AMGH, 2010. p. 1265-89. ISBN 85-6330801-6. SISTEMA IMUNOLOGICO; AGENTES IMUNOSSUPRESSORES; ESTEROIDES ADRENOCORTICAIS; INIBIDORES DA CALCINEURINA; AGENTES ANTIPROLIFERATIVOS; AGENTES ANTIMETABOLICOS; SIROLIMUS; EVEROLIMUS; AZATIOPRINA; MICOFENOLATO-MOFETILA; FTY720; ANTICORPOS POLICLONAIS; ANTICORPOS MONOCLONAIS; IMUNOESTIMULACAO; IMUNOTERAPIA PARA ESCLEROSE MULTIPLA |
| 62/297 | US=1-A / Farmacologia Farwell AP, Braverman LE. Tireóide e fármacos antitireoidianos. In: Brunton LL, Lazo JS, Parker KL. Goodman & Gilman: as bases farmacológicas da terapêutica. 11ª ed. Porto Alegre: AMGH, 2010. p. 1363-90. ISBN 85-6330801-6. TIREOIDE; INIBIDORES DA TIREOIDE; FARMACOS ANTIREOIDIANOS; IODETO; IODO RADIOATIVO |
| 63/297 | US=1-A / Farmacologia Schimmer BP, Parker KL. Hormônio adrenocorticotrópico; esteróides adrenocorticais e seus análogos sintéticos; inibidores da síntese e das ações dos hormônios adrenocorticais. In: Brunton LL, Lazo JS, Parker KL. Goodman & Gilman: as bases farmacológicas da terapêutica. 11ª ed. Porto Alegre: AMGH, 2010. p. 1433-57. ISBN 85-6330801-6. HORMONIO ADRENOCORTICOTROPICO (ACTH); CORTICOTROPINA; ESTEROIDES ADRENOCORTICAIS; CORTICOESTEROIDES; INIBIDORES DOS ESTEROIDES ADRENOCORTICAIS; ANTIGLICOCORTICOIDES |
| 64/297 | US=1-A / Farmacologia Davis SN. Insulina, agentes hipoglicemiantes orais e a farmacologia do pâncreas endócrino. In: Brunton LL, Lazo JS, Parker KL. Goodman & Gilman: as bases farmacológicas da terapêutica. 11ª ed. Porto Alegre: AMGH, 2010. p. 1459-88. ISBN 85-6330801-6. INSULINA; DIABETES MELITO; INSULINOTERAPIA; AGENTES HIPOGLICEMIANTES ORAIS; SULFONILUREIAS; REPAGLINIDA; NATEGLINIDA; BIGUANIDAS; TIAZOLIDINEDIONAS; INIBIDORES DA X-GLICOSIDASE; GLUCAGON |
| 65/297 | US=5 / Biol/Mol Koh MY, Spivak-Kroizman TR, Powis G. HIF-1alfa and cancer therapy. In: Liersch R, Berdel WE, Kessler T. Angiogenesis inhibition. New York: Springer, 2010. p. 15-34. (Recent results in cancer research) ISBN 978-3-540-78280-3. CANCER; TRATAMENTO; HIF-1; BIOLOGIA MOLECULAR DO HIF-1; REGULACAO DO HIF-1; ONCOGENICOS; HIPOXIA; INIBIDORES DE HIF-1 |
| 66/297 | US=6 / Ortopedia Taxel P, Mirza FS. Hormonal therapies in breast and prostate cancer: effects on bone and the role of bisphosphonates. In: Bronner F, Farac-Carson MC. Bone and cancer. New York: Springer-Verlag, 2009. p. 205-18. (Topics in bone biology) ISBN 978-1-84882-018-0. TERAPIAS HORMONAIS; CANCER DE MAMA; CANCER DE PROSTATA; BISFOSFONATOS; INIBIDORES DA AROMATASE; PERDA OSSEA. PREVENCAO; PERDA OSSEA. TRATAMENTO; OSTEOPOROSE |
| 67/297 | US=7 / Gastro Folprecht G. Biologicals for colorectal cancer metastases. In: Vauthey JN, Hoff PMG, Audisio RA, Poston GJ. Liver metastases. New York: Springer, 2009. p. 91-7. ISBN 978-1-84628-946-0. CANCER COLORRETAL; RECEPTORES DE FATOR DE CRESCIMENTO EPIDERMICO (EGFR); TOXICIDADE; INIBIDORES DE TIROSINA-QUINASE; TERAPIA ANTI-ANGIOGENETICA |
| 68/297 | US=14 / Dermatologia Geissler EK. Immunosuppression. In: Ulrich ESC, Euvrard S, Proby C, Bavinck JNB, Geissler EK. Skin cancer after organ transplantation. New York: Springer, 2009. p. 23-43. (Cancer Treatment and Reseach) ISBN 978-0-387-78573-8. CANCER DE PELE; TRANSPLANTE; IMUNOSSUPRESSAO; IMUNOSSUPRESSAO DE TRANSPLANTES. HISTORICO; IMUNOSSUPRESSAO FARMACOLOGICA; INIBIDORES DA CALCINEURINA; ACIDO MICOFENOLICO; INIBIDOR DE MTOR; AZATIOPRINA; CORTICOSTEROIDE; FTY720; OKT3; TIMOGLOBULINA; INTERLEUCINA-2 (IL-2); ALEMTUZUMAB; CAMPATH-1H |
| 69/297 | US=14 / Dermatologia Perrett CM, Harwood CA, McGregor JM, Karran P. Carcinogenic mechanisms related to immunosuppressive therapy. In: Ulrich ESC, Euvrard S, Proby C, Bavinck JNB, Geissler EK. Skin cancer after organ transplantation. New York: Springer, 2009. p. 123-32. (Cancer Treatment and Reseach) ISBN 978-0-387-78573-8. MECANISMOS CANCERIGENOS; TERAPIA IMUNOSSUPRESSORA; CARCINOGENESE; GLUCOCORTICOIDES; CICLOSPORINA; AZATIOPRINA; INIBIDORES DE MTOR |
| 70/297 | US=15 / Biol/Mol Stern R. Hyaluronidases in cancer biology. In: ___. Hyaluronan in cancer biology. Amsterdam: Elsevier, 2009. p. 207-20. ISBN 978-0-12-374178-3. CANCER; HIALURONIDASE; BIOLOGIA DO CANCER; EFEITO WARBURG; INIBIDORES DE HIALURONIDASE; CD44; AGENTES QUIMIOTERAPICOS |
| 71/297 | US=14 / Dermatologia Morelon E, Mahe E, Touraine JL. The role of the transplant physician in the management of skin cancers after organ transplantation. In: Ulrich ESC, Euvrard S, Proby C, Bavinck JNB, Geissler EK. Skin cancer after organ transplantation. New York: Springer, 2009. p. 377-90. (Cancer Treatment and Reseach) ISBN 978-0-387-78573-8. CANCER DE PELE; RESPONSABILIDADE MEDICA; TRANSPLANTE DE ORGAOS; CLINICO DE TRANSPLANTE; IMUNOSSUPRESSAO; INIBIDORES DE MTOR; CANCER DE PELE NAO MELANOMA |
| 72/297 | US=14 / Urologia Salonia A, Briganti A, Gallina A, Montorsi F. The utility of PDE5 inhibitors after radical prostatectomy. In: Mulhall JP. Sexual function in the prostate cancer patient. New York: Humana Press, 2009. p. 163-75. ISBN 978-1-60327-554-5. INIBIDORES DA PDE5 APOS PROSTATECTOMIA RADICAL; DISFUNCAO ERETIL; PROSTATECTOMIA RADICAL; SILDENAFIL; TADALAFIL; VARDENAFIL |
| 73/297 | US=9 / Quimioterapia Flora S, Bennicelli C, Battistella A, Bagnasco. Mechanisms of chemoprevention, antimutagenesis, and anticarcinogenesis: an overview. In: Knasmüller S, DeMarini DM, Johnson I, Gerhäuser C. Chemoprevention of cancer and DNA damage by dietary factors. Weinheim: Wiley-VCH, 2009. p. 57-72. ISBN 978-3-527-32058-5. MECANISMOS DE QUIMIOPREVENCAO; ANTIMUTAGENESE; ANTICARCINOGENESE; AGENTES QUIMIOPREVENTIVOS; MECANISMOS DE INIBIDORES DE MUTAGENESE; CARCINOGENESE |
| 74/297 | US=9 / Quimioterapia Kennedy AR. Protease inhibitors. In: Knasmüller S, DeMarini DM, Johnson I, Gerhäuser C. Chemoprevention of cancer and DNA damage by dietary factors. Weinheim: Wiley-VCH, 2009. p. 761-7. ISBN 978-3-527-32058-5. |
| 75/297 | US=6 / Quimioterapia Airley R. Classical anticancer agents. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 67-115. ISBN 978-0-470-09254-5. CLASSICOS AGENTES ANTICANCERIGENOS; AGENTE SUILANTES; ANTIMETABOLITOS; ANTIBIOTICOS ANTITUMORAIS; PRODROGAS ANTRACICLINA; SULCO DE LIGACAO DE AGENTES; INIBIDORES DA TOPOISOMERASE; INIBIDORES MITOTICOS; HORMONAIS AGENTES ANTICANCERIGENOS; REGIMES DE QUIMIOTERAPIA |
| 76/297 | US=6 / Quimioterapia Airley R. Tyrosine kinase inhibitors. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 217-23. ISBN 978-0-470-09254-5. INIBIDORES DA QUINASE DE TIROSINA; NAO-RECEPTOR INIBIDORES DE TIROSINA |
| 77/297 | US=6 / Quimioterapia Airley R. Ras inhibitors. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 225-8. ISBN 978-0-470-09254-5. |
| 78/297 | US=6 / Quimioterapia Airley R. Targeting stress proteins: HSP90 inhibitors. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 233-6. ISBN 978-0-470-09254-5. |
| 79/297 | US=6 / Quimioterapia Airley R. Histone deacetylase: an epigenetic drug target. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 255-63. ISBN 978-0-470-09254-5. INIBIDORES DE HDAC; HISTONA DEACETILASE; DROGA EPIGENETICA; HDAC; EMBALAGEM DE DNA |
| 80/297 | US=22 / Urologia Rini BI. Additional tyrosine kinase inhibitors in renal cell carcinoma. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 189-93. ISBN 978-1-58829-737-2. INIBIDORES VEGF; TKI; PTK787; AZD2171; ZK222584; INIBIDOR DE TIROSINA CINASE; PAZOPANIB |